The problem is that it is easy to IPO when an industry is booming and almost impossible when it is getting smashed. But like in the mining industry, only in boom times the funding can be secured which means now many of the small cap bios, such as Precision BIO that got in trouble and got " bailed out " by IMU, can't continue and when the tide changes a huge tech-gap, like resources squeeze due to under developing of projects, will occur. Anyone surviving the current Bio-tech downturn should come out as a huge winner if data are impressive.
GLTA
The problem is that it is easy to IPO when an industry is...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $13.40M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $18.74K | 1.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 2926082 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 74491 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| CHM (ASX) Chart |